HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

GLRE

Greenlight Capital Re, Ltd. (NASDAQ)

Financial Services — Insurance - Reinsurance

Greenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurance company worldwide. It operates through Open Market and Innovations segments. The company offers casualty reinsurance, such as automobile liability and general liability. It also provides coverages for casualty, including general liability, umbrella, multiline casualty, and workers' compensation; financial, such as mortgage, trade credit, surety, transactional liability, and financial multiline; health, which include primarily accident and critical illness; multiline comprising FAL business, coupled with multiline commercial and personal auto liability, BOP, and multiline commercial; property, including commercial property and property catastrophe; and specialty products and services, such as agriculture, cyber, marine and energy, aviation and space, specialty multiline, and WPVT which covers losses relating to war, political violence, and terrorism. The company markets its products through reinsurance brokers. Greenlight Capital Re, Ltd. was incorporated in 2004 and is headquartered in Grand Cayman, the Cayman Islands.

None
$16.36
+$0.18 (+1.11%)
Sign in to add GLRE to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$542.60M
P/E Ratio (TTM)6.93
Forward P/E10.23
EPS (TTM)$2.36
Dividend Yield-
Profit Margin11.45%
Revenue Growth-6.90%
ROE11.50%
Debt/Equity1.04
Recommendation None
Analyst Target-
Analysts-
Indexes NASDAQ

Technical Indicators

RSI (14)56.8
Beta0.33
SMA 20-
SMA 40-
52-Week High$19.39
52-Week Low$11.57
50-Day Avg$16.92
200-Day Avg$14.83
Avg Volume194.0K
Volume137.4K

Performance Analysis

NEUTRAL

GLRE presents a mixed picture with both positive and negative indicators.

~ Trading at 61% of its 52-week range.
+ RSI at 56.8 shows positive momentum.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
+ P/E of 6.9 suggests the stock may be undervalued.
- Revenue declined 6.9% year-over-year.
~ Wall Street consensus is "none".

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:11 UTC

Back to Screener Export Report